Tradewinds Capital Management, LLC Immunity Bio, Inc. Transaction History
Tradewinds Capital Management, LLC
- $371 Million
- Q1 2025
A detailed history of Tradewinds Capital Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 500 shares of IBRX stock, worth $1,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$1,400
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
238Shares Held
79.9MCall Options Held
1.08MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$57 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$32 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$21.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$12 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$9.65 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.12B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...